O

Optus Pharmaceutical Co Ltd
KOSDAQ:131030

Watchlist Manager
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Watchlist
Price: 6 960 KRW 1.16% Market Closed
Market Cap: 122.8B KRW
Section:
 

Relative Value

The Relative Value of one Optus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 6 960 KRW, Optus Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Optus Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
68
vs Industry
60
Median 3Y
1.5
Median 5Y
1.7
Industry
2.3
More Details
12.9
P/E
P/E
Price to Earnings
12.9
vs History
33
vs Industry
41
Median 3Y
12.2
Median 5Y
12.2
Industry
22.5
More Details
13.4
P/OCF
P/OCF
Price to OCF
13.4
vs History
44
vs Industry
32
Median 3Y
13.2
Median 5Y
13.1
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
10
Median 3Y
-4.6
Median 5Y
-4.6
Industry
21.4
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
61
vs Industry
72
Median 3Y
0.8
Median 5Y
0.9
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
22
vs Industry
76
Median 3Y
0.8
Median 5Y
0.8
Industry
2.5
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
17
vs Industry
79
Median 3Y
1.5
Median 5Y
1.5
Industry
5.2
More Details
6.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.7
vs History
11
vs Industry
49
Median 3Y
5.3
Median 5Y
4.7
Industry
11.9
More Details
10.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.1
vs History
12
vs Industry
45
Median 3Y
8.2
Median 5Y
6.6
Industry
16.8
More Details
9.2
EV/OCF
EV/OCF
Enterprise Value to OCF
9.2
vs History
39
vs Industry
47
Median 3Y
8.9
Median 5Y
7.4
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
23
Median 3Y
-3
Median 5Y
-3
Industry
18.6
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
61
vs Industry
79
Median 3Y
0.6
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Optus Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
122.8B KRW 1.5 12.9 6.7 10.1
JP
Hoya Corp
TSE:7741
8.1T JPY 9.3 39.3 24.7 29.5
CH
Alcon AG
SIX:ALC
31.3B CHF 3.9 37.7 15.8 30.7
DK
Coloplast A/S
CSE:COLO B
120.9B DKK 4.3 33.2 15.3 18.3
US
Align Technology Inc
NASDAQ:ALGN
11.2B USD 2.8 29.7 13.5 17.1
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP 2.8 30.5 224.4 364.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.2B CNY 9.7 26.8 24.5 24.5
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.2 19.3 91.2
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF 5.7 23.1 15 20.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.1B USD 3.5 43.3 19.6 32.7
JP
Asahi Intecc Co Ltd
TSE:7747
792.2B JPY 6.6 62.2 18.6 24.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.